Jeffrey Neul Archives
Rett syndrome drug studied at Vanderbilt approved for patients
Jul. 7, 2023—The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.
Potential Rett syndrome drug shows promising results in phase 3 trial
Dec. 6, 2021—A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.
Kennedy Center efforts enhance inclusivity in clinical trials
Jul. 30, 2021—Following the Vanderbilt Kennedy Center’s (VKC) renewal as a national Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center in 2020, the center underwent a shuffling of their four scientific cores that support basic and applied research on intellectual and developmental disabilities (IDD).
Kennedy Center receives grant to continue as IDDRC
Aug. 20, 2020—The Vanderbilt Kennedy Center (VKC) has been awarded a $6.8 million, five-year grant to continue as a national Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (IDDRC).
ACM gift aims to improve lives of children with autism spectrum disorder
Aug. 13, 2020—ACM Lifting Lives, the charitable arm of the Academy of Country Music, has made a generous gift to Vanderbilt University Medical Center for programs and research demonstrating the healing power of music to improve the lives of children with autism spectrum disorder.
Treating core Rett syndrome symptoms
Jun. 6, 2019—A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents.
Grant to help explore critical issues in Down syndrome
Oct. 25, 2018—The Vanderbilt Kennedy Center (VKC) has received a one-year $604,000 grant from the National Institute of Child Health and Human Development (NICHD) to use Vanderbilt University Medical Center electronic medical record information and biological samples to develop a deeper understanding of critical issues in Down syndrome and to provide an infrastructure for future analyses.
Celebration honors 11 university endowed chair holders
Oct. 25, 2017—Eleven Vanderbilt University faculty members named to endowed chairs were honored Oct. 23 during a festive celebration at the Student Life Center.
Neul named new director of the Vanderbilt Kennedy Center
Mar. 7, 2017—Jeffrey Neul, M.D., Ph.D., division head of Child Neurology and vice chair for Developmental Neurosciences at the University of California, San Diego, has been named the new director of the Vanderbilt Kennedy Center. He will join Vanderbilt on Aug. 1.
Rett syndrome expert Neul to speak at Kennedy Center on Friday
Dec. 13, 2016—Jeffrey Neul, M.D., Ph.D., division head of Child Neurology and vice chair for Developmental Neurosciences at the University of California, San Diego, will present a lecture on Friday, Dec. 16, at Vanderbilt Kennedy Center (VKC).
